113 related articles for article (PubMed ID: 38353737)
1. N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom.
Pucci M; Singh Jutley G; Looms J; Ford L
Clin Toxicol (Phila); 2024 Jan; 62(1):19-25. PubMed ID: 38353737
[TBL] [Abstract][Full Text] [Related]
2. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS).
Walton SE; Krotulski AJ; Logan BK
J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157
[TBL] [Abstract][Full Text] [Related]
3. Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework.
Krotulski AJ; Papsun DM; Kacinko SL; Logan BK
J Anal Toxicol; 2020 Jul; 44(6):521-530. PubMed ID: 32091095
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel opioid,
Calello DP; Aldy K; Jefri M; Nguyen TT; Krotulski A; Logan B; Brent J; Wax P; Walton S; Manini AF;
Clin Toxicol (Phila); 2022 Sep; 60(9):1067-1069. PubMed ID: 35708103
[TBL] [Abstract][Full Text] [Related]
5. Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats.
Walton SE; Krotulski AJ; Glatfelter GC; Walther D; Logan BK; Baumann MH
Psychopharmacology (Berl); 2023 Jan; 240(1):185-198. PubMed ID: 36526866
[TBL] [Abstract][Full Text] [Related]
6. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
7. Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study.
Shover CL; Falasinnu TO; Freedman RB; Humphreys K
J Addict Med; 2021 Sep-Oct 01; 15(5):429-431. PubMed ID: 33234804
[TBL] [Abstract][Full Text] [Related]
8. Isotonitazene, a novel psychoactive substance opioid, detected in two cases following a local surge in opioid overdoses.
De Baerdemaeker KSC; Dines AM; Hudson S; Sund LJ; Waters ML; Hunter LJ; Blundell MS; Archer JRH; Wood DM; Dargan PI
QJM; 2023 Feb; 116(2):115-119. PubMed ID: 35169852
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid receptor selective superagonists produce prolonged respiratory depression.
Malcolm NJ; Palkovic B; Sprague DJ; Calkins MM; Lanham JK; Halberstadt AL; Stucke AG; McCorvy JD
iScience; 2023 Jul; 26(7):107121. PubMed ID: 37416459
[TBL] [Abstract][Full Text] [Related]
10. In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.
De Vrieze LM; Walton SE; Pottie E; Papsun D; Logan BK; Krotulski AJ; Stove CP; Vandeputte MM
Arch Toxicol; 2024 Jun; ():. PubMed ID: 38877156
[TBL] [Abstract][Full Text] [Related]
11. Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene.
Taoussi O; Berardinelli D; Zaami S; Tavoletta F; Basile G; Kronstrand R; Auwärter V; Busardò FP; Carlier J
Arch Toxicol; 2024 Jul; 98(7):2101-2116. PubMed ID: 38582802
[TBL] [Abstract][Full Text] [Related]
12. Isotonitazene, a synthetic opioid from an emerging family: The nitazenes.
Bendjilali-Sabiani JJ; Eiden C; Lestienne M; Cherki S; Gautre D; Van den Broek T; Mathieu O; Peyrière H
Therapie; 2024 May; ():. PubMed ID: 38845278
[TBL] [Abstract][Full Text] [Related]
13. Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland.
Mueller F; Bogdal C; Pfeiffer B; Andrello L; Ceschi A; Thomas A; Grata E
Forensic Sci Int; 2021 Mar; 320():110686. PubMed ID: 33497988
[TBL] [Abstract][Full Text] [Related]
14. Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review.
Montanari E; Madeo G; Pichini S; Busardò FP; Carlier J
Ther Drug Monit; 2022 Aug; 44(4):494-510. PubMed ID: 35149665
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of "Nitazene" 2-Benzylbenzimidazole Synthetic Opioids.
Vandeputte MM; Van Uytfanghe K; Layle NK; St Germaine DM; Iula DM; Stove CP
ACS Chem Neurosci; 2021 Apr; 12(7):1241-1251. PubMed ID: 33759494
[TBL] [Abstract][Full Text] [Related]
16. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
[TBL] [Abstract][Full Text] [Related]
17. Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene.
Blanckaert P; Cannaert A; Van Uytfanghe K; Hulpia F; Deconinck E; Van Calenbergh S; Stove C
Drug Test Anal; 2020 Apr; 12(4):422-430. PubMed ID: 31743619
[TBL] [Abstract][Full Text] [Related]
18. Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City.
Pardi J; Ford S; Cooper G
J Anal Toxicol; 2023 Nov; 47(8):648-655. PubMed ID: 37638699
[TBL] [Abstract][Full Text] [Related]
19. Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England.
King A; Hill SL; Pucci M; Bailey G; Keating L; Macfarlane R; Cantle F; Hudson S; Thomas SHL
Clin Toxicol (Phila); 2022 Oct; 60(10):1094-1098. PubMed ID: 35943421
[TBL] [Abstract][Full Text] [Related]
20. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
Bonnet U; Specka M; Kanti AK; Scherbaum N
Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
